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Frederico Bastos Gonçalves *
Department of Angiology and Vascular Surgery, Hospital de Santa Marta, CHLC & NOVA Medical School, Lisbon, PortugalIonizing radiation exposure is worrisome for all vascular
physicians. Despite ongoing research, the full extent of
biological damage caused by repeated exposure during
vascular intervention remains unclear e especially for long
and complex operations in high volume centres. Radiation
safety is therefore a priority and should be taken very
seriously.
The manuscript by Hertault et al.1 carries an important
message e we can reduce radiation exposure using strict
protocols based on the ALARA principle. It is very inter-
esting to observe that different centres from different
countries can achieve homogeneous profiles by adhering to
a common protocol, when performing standard infrarenal
EVAR. More importantly, the reported exposure rates are
much lower (by a factor greater than 10) than those re-
ported in previous meta-analyses,2,3 which is a strong in-
dicator of the advantage of the proposed strategy and sets
the example for others to follow.
The obvious limitation of the study is the lack of a
comparator. That makes it very difficult to measure the
actual benefit of individual components of the protocol and
in particular of image fusion. In compensation, the authors
resort to historical controls with their inherent risk of bias
and also not accounting for technological progress and
learning curve of those used for comparison. Furthermore,
for standard EVAR cases, mobile C-arms are usually of suf-
ficient quality and associated with less radiation exposure.2
It is likely that fusion in hybrid rooms has greater benefit in
limiting contrast administration and less in reducing radia-
tion exposure if one avoids unnecessary digital subtraction
aquisitions, being particularly useful for complex cases
when multiple vessel catheterisation is necessary.2 Fusion
may actually increase radiation exposure to the patient if a
cone beam CT is performed for registration3 (not the case in
this study where bi-view registration was used). In the
literature as in this report, the accuracy of registration is
rarely mentioned. Moreover, there is no evidence suggest-
ing fusion alone allows comparable accuracy for endograft
positioning, especially if the patient is treated under local
anaesthesia as patient movement limits the use of fusionDOI of original article: https://doi.org/10.1016/j.ejvs.2018.05.001
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https://doi.org/10.1016/j.ejvs.2018.05.029significantly. Although desirable, the actual added value of
fusion in standard EVAR remains to be demonstrated and
unavailability of fusion should not detract from adopting
the other (potentially more relevant) recommendations.
Another important aspect not explored by Hertault et al.
is the effect of personal protection such as shields and lead
drapes. The study uses dose area product (good surrogate
for patient exposure) as an endpoint. For professionals,
however, personal exposure is of major relevance. If
dosimeter measurements were used, one could fully assess
the efficacy of the protocol in terms of professional expo-
sure risk.
Lastly, the study is a registry not a trial, therefore more
prone to bias. The authors argue that included centres
represent real world practice. However, these are still
expert centres with access to hybrid rooms and fusion
technology, so arguably not the real world at all. And just
the mere fact of participating in such a registry is a signal of
concern over radiation safety.
Despite the above, it is most relevant to demonstrate
that application of a multifactorial but relatively simple
protocol results in homogeneous exposure reduction and
hopefully safer practice for patients and doctors. This study
sets the standard, with or without fusion. Let’s hope doc-
tors, technicians, administrators and regulators follow.REFERENCES
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